How does real innovation in cancer therapy begin? Step into the world of preclinical drug discovery, where every molecule—and every lesson—matters.

In this episode of Oncology Voice Network Podcast, Host Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.

Together, they explore how personal stories, cross-functional teamwork, and the willingness to share both successes and failures can reshape outcomes for cancer patients.

Dr. Fine reflects on the human inspiration behind his decades of work, breaks the myth of the lone scientist by emphasizing the power of collaboration, and explains how preclinical data guides every step of a therapy’s path to patients. He also emphasizes the importance of open partnerships among pharma, biotech, payers, and patient advocates. Looking ahead, they discuss big ideas shaping the future, from data sharing and adaptive trials to more patient-centered strategies.

Discover why a new era of shared innovation is essential to accelerating breakthroughs and ensuring no patient is left behind. Tune in now.